1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceuticals and Biotechnology R&D Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Drug
1.2.3 Medical Equipment
1.2.4 Vaccine
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmaceuticals and Biotechnology R&D Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Homecare
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceuticals and Biotechnology R&D Market Perspective (2017-2028)
2.2 Pharmaceuticals and Biotechnology R&D Growth Trends by Region
2.2.1 Pharmaceuticals and Biotechnology R&D Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pharmaceuticals and Biotechnology R&D Historic Market Size by Region (2017-2022)
2.2.3 Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Region (2023-2028)
2.3 Pharmaceuticals and Biotechnology R&D Market Dynamics
2.3.1 Pharmaceuticals and Biotechnology R&D Industry Trends
2.3.2 Pharmaceuticals and Biotechnology R&D Market Drivers
2.3.3 Pharmaceuticals and Biotechnology R&D Market Challenges
2.3.4 Pharmaceuticals and Biotechnology R&D Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceuticals and Biotechnology R&D Players by Revenue
3.1.1 Global Top Pharmaceuticals and Biotechnology R&D Players by Revenue (2017-2022)
3.1.2 Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Players (2017-2022)
3.2 Global Pharmaceuticals and Biotechnology R&D Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceuticals and Biotechnology R&D Revenue
3.4 Global Pharmaceuticals and Biotechnology R&D Market Concentration Ratio
3.4.1 Global Pharmaceuticals and Biotechnology R&D Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceuticals and Biotechnology R&D Revenue in 2021
3.5 Pharmaceuticals and Biotechnology R&D Key Players Head office and Area Served
3.6 Key Players Pharmaceuticals and Biotechnology R&D Product Solution and Service
3.7 Date of Enter into Pharmaceuticals and Biotechnology R&D Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceuticals and Biotechnology R&D Breakdown Data by Type
4.1 Global Pharmaceuticals and Biotechnology R&D Historic Market Size by Type (2017-2022)
4.2 Global Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Type (2023-2028)
5 Pharmaceuticals and Biotechnology R&D Breakdown Data by Application
5.1 Global Pharmaceuticals and Biotechnology R&D Historic Market Size by Application (2017-2022)
5.2 Global Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pharmaceuticals and Biotechnology R&D Market Size (2017-2028)
6.2 North America Pharmaceuticals and Biotechnology R&D Market Size by Type
6.2.1 North America Pharmaceuticals and Biotechnology R&D Market Size by Type (2017-2022)
6.2.2 North America Pharmaceuticals and Biotechnology R&D Market Size by Type (2023-2028)
6.2.3 North America Pharmaceuticals and Biotechnology R&D Market Share by Type (2017-2028)
6.3 North America Pharmaceuticals and Biotechnology R&D Market Size by Application
6.3.1 North America Pharmaceuticals and Biotechnology R&D Market Size by Application (2017-2022)
6.3.2 North America Pharmaceuticals and Biotechnology R&D Market Size by Application (2023-2028)
6.3.3 North America Pharmaceuticals and Biotechnology R&D Market Share by Application (2017-2028)
6.4 North America Pharmaceuticals and Biotechnology R&D Market Size by Country
6.4.1 North America Pharmaceuticals and Biotechnology R&D Market Size by Country (2017-2022)
6.4.2 North America Pharmaceuticals and Biotechnology R&D Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Pharmaceuticals and Biotechnology R&D Market Size (2017-2028)
7.2 Europe Pharmaceuticals and Biotechnology R&D Market Size by Type
7.2.1 Europe Pharmaceuticals and Biotechnology R&D Market Size by Type (2017-2022)
7.2.2 Europe Pharmaceuticals and Biotechnology R&D Market Size by Type (2023-2028)
7.2.3 Europe Pharmaceuticals and Biotechnology R&D Market Share by Type (2017-2028)
7.3 Europe Pharmaceuticals and Biotechnology R&D Market Size by Application
7.3.1 Europe Pharmaceuticals and Biotechnology R&D Market Size by Application (2017-2022)
7.3.2 Europe Pharmaceuticals and Biotechnology R&D Market Size by Application (2023-2028)
7.3.3 Europe Pharmaceuticals and Biotechnology R&D Market Share by Application (2017-2028)
7.4 Europe Pharmaceuticals and Biotechnology R&D Market Size by Country
7.4.1 Europe Pharmaceuticals and Biotechnology R&D Market Size by Country (2017-2022)
7.4.2 Europe Pharmaceuticals and Biotechnology R&D Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size (2017-2028)
8.2 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Type
8.2.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Share by Type (2017-2028)
8.3 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Application
8.3.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Share by Application (2017-2028)
8.4 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region
8.4.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmaceuticals and Biotechnology R&D Market Size (2017-2028)
9.2 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Type
9.2.1 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Type (2017-2022)
9.2.2 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Type (2023-2028)
9.2.3 Latin America Pharmaceuticals and Biotechnology R&D Market Share by Type (2017-2028)
9.3 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Application
9.3.1 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Application (2017-2022)
9.3.2 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Application (2023-2028)
9.3.3 Latin America Pharmaceuticals and Biotechnology R&D Market Share by Application (2017-2028)
9.4 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Country
9.4.1 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Country (2017-2022)
9.4.2 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size (2017-2028)
10.2 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Type
10.2.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Share by Type (2017-2028)
10.3 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Application
10.3.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Share by Application (2017-2028)
10.4 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country
10.4.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ROCHE
11.1.1 ROCHE Company Details
11.1.2 ROCHE Business Overview
11.1.3 ROCHE Pharmaceuticals and Biotechnology R&D Introduction
11.1.4 ROCHE Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.1.5 ROCHE Recent Developments
11.2 JOHNSON & JOHNSON
11.2.1 JOHNSON & JOHNSON Company Details
11.2.2 JOHNSON & JOHNSON Business Overview
11.2.3 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Introduction
11.2.4 JOHNSON & JOHNSON Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.2.5 JOHNSON & JOHNSON Recent Developments
11.3 MERCK
11.3.1 MERCK Company Details
11.3.2 MERCK Business Overview
11.3.3 MERCK Pharmaceuticals and Biotechnology R&D Introduction
11.3.4 MERCK Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.3.5 MERCK Recent Developments
11.4 NOVARTIS
11.4.1 NOVARTIS Company Details
11.4.2 NOVARTIS Business Overview
11.4.3 NOVARTIS Pharmaceuticals and Biotechnology R&D Introduction
11.4.4 NOVARTIS Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.4.5 NOVARTIS Recent Developments
11.5 PFIZER
11.5.1 PFIZER Company Details
11.5.2 PFIZER Business Overview
11.5.3 PFIZER Pharmaceuticals and Biotechnology R&D Introduction
11.5.4 PFIZER Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.5.5 PFIZER Recent Developments
11.6 SANOFI
11.6.1 SANOFI Company Details
11.6.2 SANOFI Business Overview
11.6.3 SANOFI Pharmaceuticals and Biotechnology R&D Introduction
11.6.4 SANOFI Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.6.5 SANOFI Recent Developments
11.7 BAYER
11.7.1 BAYER Company Details
11.7.2 BAYER Business Overview
11.7.3 BAYER Pharmaceuticals and Biotechnology R&D Introduction
11.7.4 BAYER Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.7.5 BAYER Recent Developments
11.8 BRISTOL-MYERS SQUIBB
11.8.1 BRISTOL-MYERS SQUIBB Company Details
11.8.2 BRISTOL-MYERS SQUIBB Business Overview
11.8.3 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Introduction
11.8.4 BRISTOL-MYERS SQUIBB Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.8.5 BRISTOL-MYERS SQUIBB Recent Developments
11.9 ASTRAZENECA
11.9.1 ASTRAZENECA Company Details
11.9.2 ASTRAZENECA Business Overview
11.9.3 ASTRAZENECA Pharmaceuticals and Biotechnology R&D Introduction
11.9.4 ASTRAZENECA Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.9.5 ASTRAZENECA Recent Developments
11.10 GLAXOSMITHKLINE
11.10.1 GLAXOSMITHKLINE Company Details
11.10.2 GLAXOSMITHKLINE Business Overview
11.10.3 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Introduction
11.10.4 GLAXOSMITHKLINE Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.10.5 GLAXOSMITHKLINE Recent Developments
11.11 ABBVIE
11.11.1 ABBVIE Company Details
11.11.2 ABBVIE Business Overview
11.11.3 ABBVIE Pharmaceuticals and Biotechnology R&D Introduction
11.11.4 ABBVIE Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.11.5 ABBVIE Recent Developments
11.12 ELI LILLY
11.12.1 ELI LILLY Company Details
11.12.2 ELI LILLY Business Overview
11.12.3 ELI LILLY Pharmaceuticals and Biotechnology R&D Introduction
11.12.4 ELI LILLY Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.12.5 ELI LILLY Recent Developments
11.13 BOEHRINGER SOHN
11.13.1 BOEHRINGER SOHN Company Details
11.13.2 BOEHRINGER SOHN Business Overview
11.13.3 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Introduction
11.13.4 BOEHRINGER SOHN Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.13.5 BOEHRINGER SOHN Recent Developments
11.14 AMGEN
11.14.1 AMGEN Company Details
11.14.2 AMGEN Business Overview
11.14.3 AMGEN Pharmaceuticals and Biotechnology R&D Introduction
11.14.4 AMGEN Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.14.5 AMGEN Recent Developments
11.15 GILEAD SCIENCES
11.15.1 GILEAD SCIENCES Company Details
11.15.2 GILEAD SCIENCES Business Overview
11.15.3 GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Introduction
11.15.4 GILEAD SCIENCES Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.15.5 GILEAD SCIENCES Recent Developments
11.16 TAKEDA PHARMACEUTICAL
11.16.1 TAKEDA PHARMACEUTICAL Company Details
11.16.2 TAKEDA PHARMACEUTICAL Business Overview
11.16.3 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Introduction
11.16.4 TAKEDA PHARMACEUTICAL Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.16.5 TAKEDA PHARMACEUTICAL Recent Developments
11.17 NOVO NORDISK
11.17.1 NOVO NORDISK Company Details
11.17.2 NOVO NORDISK Business Overview
11.17.3 NOVO NORDISK Pharmaceuticals and Biotechnology R&D Introduction
11.17.4 NOVO NORDISK Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.17.5 NOVO NORDISK Recent Developments
11.18 BIOGEN
11.18.1 BIOGEN Company Details
11.18.2 BIOGEN Business Overview
11.18.3 BIOGEN Pharmaceuticals and Biotechnology R&D Introduction
11.18.4 BIOGEN Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.18.5 BIOGEN Recent Developments
11.19 ABBOTT
11.19.1 ABBOTT Company Details
11.19.2 ABBOTT Business Overview
11.19.3 ABBOTT Pharmaceuticals and Biotechnology R&D Introduction
11.19.4 ABBOTT Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.19.5 ABBOTT Recent Developments
11.20 ASTELLAS PHARMA
11.20.1 ASTELLAS PHARMA Company Details
11.20.2 ASTELLAS PHARMA Business Overview
11.20.3 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Introduction
11.20.4 ASTELLAS PHARMA Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.20.5 ASTELLAS PHARMA Recent Developments
11.21 TEVA PHARMACEUTICAL INDUSTRIES
11.21.1 TEVA PHARMACEUTICAL INDUSTRIES Company Details
11.21.2 TEVA PHARMACEUTICAL INDUSTRIES Business Overview
11.21.3 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Introduction
11.21.4 TEVA PHARMACEUTICAL INDUSTRIES Revenue in Pharmaceuticals and Biotechnology R&D Business (2017-2022)
11.21.5 TEVA PHARMACEUTICAL INDUSTRIES Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
